Cargando…

MicroRNAs and Nonalcoholic Steatohepatitis: A Review

Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic syndrome caused by fat deposition in hepatocytes. Patients with nonalcoholic steatohepatitis (NASH), an advanced form of NAFLD with severe fibrosis, are at high risk for liver-related complications, including hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morishita, Asahiro, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Kobara, Hideki, Ono, Masafumi, Himoto, Takashi, Masaki, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572537/ https://www.ncbi.nlm.nih.gov/pubmed/37833930 http://dx.doi.org/10.3390/ijms241914482

Ejemplares similares

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review
por: Morishita, Asahiro, et al.
Publicado: (2021)

MicroRNA Interference in Hepatic Host-Pathogen Interactions
por: Morishita, Asahiro, et al.
Publicado: (2021)

Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
por: Nakahara, Mai, et al.
Publicado: (2022)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
por: Takuma, Kei, et al.
Publicado: (2022)

Giant cutaneous metastasis from hepatocellular carcinoma
por: Morishita, Asahiro, et al.
Publicado: (2022)

Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literature
por: Oura, Kyoko, et al.
Publicado: (2021)

Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis
por: Fujita, Koji, et al.
Publicado: (2019)

Verification of B-lymphocyte activating factor’s involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease
por: Himoto, Takashi, et al.
Publicado: (2017)

Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up
por: Tadokoro, Tomoko, et al.
Publicado: (2021)

Galectin-9 in Gastroenterological Cancer
por: Morishita, Asahiro, et al.
Publicado: (2023)

Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
por: Kohno, Tomoki, et al.
Publicado: (2020)

Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs
por: Fujita, Koji, et al.
Publicado: (2016)

Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV
por: Tadokoro, Tomoko, et al.
Publicado: (2017)

MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis
por: KATSURA, AKIKO, et al.
Publicado: (2015)

Albumin–Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study
por: Fujita, Koji, et al.
Publicado: (2019)

Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis
por: Shi, Tingting, et al.
Publicado: (2020)

Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017)

Association between microRNA-527 and glypican-3 in hepatocellular carcinoma
por: Nomura, Kei, et al.
Publicado: (2021)

The Role of microRNAs in Cholangiocarcinoma
por: Shi, Tingting, et al.
Publicado: (2021)

Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients
por: Fujita, Koji, et al.
Publicado: (2018)

Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
por: Oura, Kyoko, et al.
Publicado: (2020)

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
por: Morishita, Asahiro, et al.
Publicado: (2022)

Albumin platelet product as a novel score for liver fibrosis stage and prognosis
por: Fujita, Koji, et al.
Publicado: (2021)

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
por: Oura, Kyoko, et al.
Publicado: (2021)

Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
por: Oura, Kyoko, et al.
Publicado: (2022)

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy
por: Oura, Kyoko, et al.
Publicado: (2023)

Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report
por: Sato, Yudai, et al.
Publicado: (2023)

Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017)

Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection
por: Fujita, Koji, et al.
Publicado: (2018)

Nutritional Support for Alcoholic Liver Disease
por: Tadokoro, Tomoko, et al.
Publicado: (2023)

Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study
por: Tani, Joji, et al.
Publicado: (2021)

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
por: Manabe, Takushi, et al.
Publicado: (2022)

Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease
por: Manabe, Takushi, et al.
Publicado: (2023)

Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
por: Morishita, Asahiro, et al.
Publicado: (2021)

Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir
por: Morishita, Asahiro, et al.
Publicado: (2018)

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C
por: Fujita, Koji, et al.
Publicado: (2019)

MicroRNA profiles in various hepatocellular carcinoma cell lines
por: Morishita, Asahiro, et al.
Publicado: (2016)

Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three-dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion
por: Nomura, Takako, et al.
Publicado: (2019)

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study
por: Tani, Joji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iq1pq0jqn4njsl0qorae1hl2j4